Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers?
- PMID: 38557145
- DOI: 10.1176/appi.ajp.20240100
Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers?
Keywords: Biological Markers; Schizophrenia Spectrum and Other Psychotic Disorders.
Conflict of interest statement
Dr. Light has served as a consultant for Cerevel, Johnson & Johnson, Neurocrine, NeuroSig, and Sosei-Heptares. Dr. Swerdlow reports no financial relationships with commercial interests.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical